Extensive molecular screening for hereditary non-polyposis colorectal cancer

scientific article published on February 2000

Extensive molecular screening for hereditary non-polyposis colorectal cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1019283609
P356DOI10.1054/BJOC.1999.1014
P8608Fatcat IDrelease_5otoq3ofmneihkgw6jew6w3zji
P932PMC publication ID2374417
P698PubMed publication ID10732761
P5875ResearchGate publication ID12582974

P50authorJean-Pierre PignonQ57419648
P2093author name stringP Lasser
P Rougier
J Bénard
J C Sabourin
B Bressac-de Paillerets
I Lefrère
D Couturier
S Grandjouan
M L Le Bihan
B Dieumegard
Bellefqih
P2860cites workUbiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesisQ22122362
Mutations of two PMS homologues in hereditary nonpolyposis colon cancerQ24318484
Mutation of a mutL homolog in hereditary colon cancerQ28114939
Lessons from hereditary colorectal cancerQ28131788
Cancer-susceptibility genes. Gatekeepers and caretakersQ28236512
Binding of mismatched microsatellite DNA sequences by the human MSH2 proteinQ28241673
Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancerQ28253384
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancerQ28256988
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancerQ28257360
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomasQ28269089
The 1993-94 Généthon human genetic linkage mapQ28288492
Isolation of an hMSH2-p160 Heterodimer That Restores DNA Mismatch Repair to Tumor CellsQ28292781
Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomasQ70972741
A truncated hMSH2 transcript occurs as a common variant in the population: implications for genetic diagnosisQ71067607
Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancerQ71689243
Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genesQ71733947
DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignanciesQ71814434
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instabilityQ72127255
Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancersQ73157872
Germline hMSH2 and hMLH1 gene mutations in incomplete HNPCC familiesQ73943040
MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancerQ74323855
Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor proteinQ29614383
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinomaQ29615026
Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell linesQ29620526
p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding.Q30428424
A simple model for carcinogenesis of colorectal cancers with microsatellite instability.Q33767129
A naturally occurring hPMS2 mutation can confer a dominant negative mutator phenotypeQ33772742
Excess beta-catenin promotes accumulation of transcriptionally active p53.Q33891005
Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.Q34732921
Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequencesQ35753544
Genetic instability in human ovarian cancer cell lines.Q35791709
Bcl-2 expression in normal endometrium during the menstrual cycle.Q35834144
RNA-based mutation screening in hereditary nonpolyposis colorectal cancerQ35882089
Alternative genetic pathways in colorectal carcinogenesis.Q36637607
Genetic instability occurs in the majority of young patients with colorectal cancerQ38297232
Alternative splicing of hMSH2 in normal human tissuesQ38346418
Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch Syndrome).Q40969554
Familial risk and colon cancerQ40969561
Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibilityQ41061594
Conditional mutator phenotypes in hMSH2-deficient tumor cell linesQ41091724
Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated reviewQ41127594
Loss of DNA mismatch repair in acquired resistance to cisplatinQ41189901
Germline HNPCC gene variants have little influence on the risk for sporadic colorectal cancerQ42005199
MLH1, PMS1, and MSH2 interactions during the initiation of DNA mismatch repair in yeastQ42427955
Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancerQ45345220
Functional analysis of human MLH1 mutations in Saccharomyces cerevisiaeQ47713981
Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindredQ48044118
BRCA1 mutations in primary breast and ovarian carcinomasQ48078473
Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancerQ48084125
Tumour spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with "suspected HNPCC". A population-based study in northern Italy. Colorectal Cancer Study Group.Q53389780
Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression.Q53439660
Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer.Q53452567
Microsatellite instability analysis: a multicenter study for reliability and quality control.Q54225696
Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.Q54417578
HNPCC associated with germline mutation in the TGF-beta type II receptor gene.Q55067518
Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]Q56893811
Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the DiseaseQ57567959
Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancerQ57568035
Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patientsQ57570041
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda GuidelinesQ57978042
K-ras andp53 mutations in hereditary non-polyposis colorectal cancersQ61196108
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)Q62978412
The tumour spectrum in hereditary non-polyposis colorectal cancer: A study of 24 kindreds in the netherlandsQ62978416
Tumor variation in three extended Lynch syndrome II kindredsQ68404297
Extracolonic cancer in hereditary nonpolyposis colorectal cancerQ70557907
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectcolorectal cancerQ188874
colorectal carcinomaQ25493920
P304page(s)871-880
P577publication date2000-02-01
P1433published inBritish Journal of CancerQ326309
P1476titleExtensive molecular screening for hereditary non-polyposis colorectal cancer
P478volume82

Reverse relations

cites work (P2860)
Q36507457Accuracy of MSI testing in predicting germline mutations of MSH2 and MLH1: a case study in Bayesian meta-analysis of diagnostic tests without a gold standard
Q35700015An American founder mutation in MLH1.
Q59411242Assessing colorectal cancer mismatch repair status in the modern era: a survey of current practices and re-evaluation of the role of microsatellite instability testing
Q33513323Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast
Q57569926Classification of ambiguous mutations in DNA mismatch repair genes identified in a population-based study of colorectal cancer
Q52005531Clinical and molecular biologic characteristics of early-onset versus late-onset colorectal carcinoma in Filipinos.
Q36178327Clinical characteristics and diagnosis of patients with hereditary nonpolyposis colorectal cancer
Q36415689Clinicopathological and molecular genetic analysis of 4 typical Chinese HNPCC families.
Q36643467Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients
Q35748966Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors
Q34568596DNA mismatch repair defects: role in colorectal carcinogenesis
Q61758596Efficacy and safety of a cisplatin and paclitaxel induction regimen followed by chemoradiotherapy for patients with locally advanced head and neck squamous cell carcinoma
Q93012448Functional interrogation of Lynch syndrome-associated MSH2 missense variants via CRISPR-Cas9 gene editing in human embryonic stem cells
Q34557954HMLH1 gene mutation in gastric cancer patients and their kindred
Q36451916Human mismatch repair protein hMutLα is required to repair short slipped-DNAs of trinucleotide repeats
Q36412420Human mutL homolog 1 expression characteristic and prognostic effect on patients with sporadic colorectal cancer
Q35760971Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.
Q80186521Immunohistochemical staining of hMLH1 and hMSH2 reflects microsatellite instability status in ovarian carcinoma
Q36492931Immunohistochemistry and microsatellite instability analysis in molecular subtyping of colorectal carcinoma based on mismatch repair competency
Q39514722Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry
Q38661498Investigation of correlation between mutational status in key EGFR signaling genes and prognosis of stage II colorectal cancer
Q34579284Is reduced expression of mismatch repair genes MLH1 and MSH2 in patients with sporadic colorectal cancer related to their prognosis?
Q35057393Mismatch repair protein expression in colorectal cancer
Q42379696Molecular analysis: microsatellity instability and loss of heterozygosity of tumor suppressor gene in hereditary non-polyposis colorectal cancers (HNPCC).
Q36821500Oligonucleotide-directed mutagenesis screen to identify pathogenic Lynch syndrome-associated MSH2 DNA mismatch repair gene variants
Q30906288Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers
Q48375665Performance of Lynch syndrome predictive models in quantifying the likelihood of germline mutations in patients with abnormal MLH1 immunoexpression
Q36882484Prediction of germline mutations and cancer risk in the Lynch syndrome
Q34633911Prevalence of pathological germline mutations of hMLH1 and hMSH2 genes in colorectal cancer
Q30413890Q48P mutation in the hMLH1 gene associated with Lynch syndrome in three Hungarian families
Q35904483The utility of immunohistochemical detection of DNA mismatch repair gene proteins.
Q36246500Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome
Q81160714Value of microsatellite instability typing in detecting hereditary non-polyposis colorectal cancer. A prospective multicentric study by the Association Aquitaine Gastro

Search more.